title: Mouse fetal and embryonic liver cells differentiate human umbilical cord blood progenitors into CD56-negative natural killer cell precursors in the absence of interleukin-15.
abstract: OBJECTIVE
  Human natural killer (NK) cell maturation involves the orderly acquisition of NK cell receptors. Our aim was to understand how stromal interactions and cytokines are important in this developmental process.
  
  
  METHODS
  Human umbilical cord blood (UCB) CD34(+)/Lin(-)/CD38(-) cells were cultured on two murine stromal cell lines (AFT024 and EL08-1D2) in a switch culture to study NK cell development.
  
  
  RESULTS
  When human progenitors were cultured on AFT024 with interleukin (IL)-3 and Flt3 ligand (Flt3L) in the absence of interleukin (IL)-15, NK cell differentiation occurred, albeit at low frequency. These conditions favored the accumulation of CD56(-) NK cell precursors (CD34(+)CD7(-), CD34(+)CD7(+), and CD34(-)CD7(+) cells), which are populations rare in adult blood but abundant in fresh UCB. In secondary culture, addition of IL-3 or IL-3 + Flt3L to IL-15 increased the absolute number of CD56(+) NK cells from precursors and the acquisition of CD94 and killer immunoglobulin-like receptors (KIR). To further explore the microenvironment in early NK cell maturation, a cell line derived from murine embryonic liver (EL08-1D2) was studied. NK cell development and KIR acquisition was superior with EL08-1D2, which supported the differentiation of NK cell precursors, NK cell commitment, and proliferation.
  
  
  CONCLUSIONS
  Although the earliest events in NK cell maturation do not require exogenous human IL-15, it is required at a later stage of NK cell commitment. At a minimum, murine stroma, IL-3, and Flt3L are required to recapitulate early NK cell development and differentiation into distinct NK cell precursors. EL08-1D2 induces KIR acquisition suggesting that extrinsic signals in NK cell development are conserved between mouse and man.
authors.affiliation: Division of Medical, University of Minnesota Cancer Center, University of Minnesota Medical School, Minneapolis, MN 55455, USA.
authors.forename: Valarie
authors.initials: V
authors.lastname: McCullar
authors.forename: Robert
authors.initials: R
authors.lastname: Oostendorp
authors.forename: Angela
authors.initials: A
authors.lastname: Panoskaltsis-Mortari
authors.forename: Gong
authors.initials: G
authors.lastname: Yun
authors.forename: Charles T
authors.initials: CT
authors.lastname: Lutz
authors.forename: John E
authors.initials: JE
authors.lastname: Wagner
authors.forename: Jeffrey S
authors.initials: JS
authors.lastname: Miller
mesh_terms: D000818:Animals; D019002:CD56 Antigen / Q000276:immunology; D002454:Cell Differentiation / Q000187:drug effects; D002478:Cells, Cultured; D018920:Coculture Techniques / Q000379:methods; D005312:Fetal Blood / Q000166:cytology* / Q000187:drug effects; D006412:Hematopoietic Stem Cells / Q000166:cytology* / Q000187:drug effects; D006801:Humans; D019409:Interleukin-15 / Q000172:deficiency / Q000494:pharmacology; D007377:Interleukin-3 / Q000494:pharmacology; D007694:Killer Cells, Natural / Q000166:cytology* / Q000276:immunology; D008099:Liver / Q000166:cytology* / Q000196:embryology; D008565:Membrane Proteins / Q000494:pharmacology; D051379:Mice; D054340:Receptors, KIR / Q000276:immunology; D017154:Stromal Cells / Q000166:cytology / Q000276:immunology
chemical_list: D019002:CD56 Antigen; D019409:Interleukin-15; D007377:Interleukin-3; D008565:Membrane Proteins; D054340:Receptors, KIR; C084881:flt3 ligand protein